Scott Schlackman sold $160k of MED
director at MEDIFAST INC. 4,053 shares at an average of $39.44, traded Mar 8, 2024, filed Mar 12, 2024.
Score components
- +15RoleDirector
- +11Trade size$160k at market
- +10Share of holdings soldSold 34% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001628280-24-010641, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 8, 2024 | MOption exercise Common Stock | +1,300 | $27.68 | $36k | 11,838 | Mar 12, 2024 |
| Mar 8, 2024 | SOpen-market sale Common Stock | -1,300 | $39.41 | $51k | 10,538 | Mar 12, 2024 |
| Mar 8, 2024 | SOpen-market sale Common Stock | -2,753 | $39.46 | $109k | 7,785 | Mar 12, 2024 |
| Mar 8, 2024 | MOption exercise Stock Option (Right to Buy)derivative | -1,300 | $0.00 | $0 | 0 | Mar 12, 2024 |
Related signals
Other insiders at MEDIFAST INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | MEDIFAST INC | Daniel R Chard Chairman & CEO | $226k 19,089 shares | -13% | |
| 45Moderate | MEDbuy MEDIFAST INC | Parsa Kiai director | $529k 43,150 shares | +6% | |
| 26Weak | MEDbuy MEDIFAST INC | Parsa Kiai director | $52k 4,329 shares | +1% | |
| 45Moderate | MEDbuy MEDIFAST INC | Parsa Kiai director | $843k 72,487 shares | +12% | |
| 30Weak | MEDbuy MEDIFAST INC | Scott Schlackman director | $63k 5,000 shares | +20% | |
| 63Notable | MEDbuy MEDIFAST INC | Daniel R Chard Chairman & CEO | $179k 17,678 shares | - | |
| 38Weak | MEDbuy MEDIFAST INC | Daniel R Chard Chairman & CEO | $5,003 381 shares | +0% | |
| 43Moderate | MEDIFAST INC | Jeffrey J Brown director | $11k 155 shares | +4% | |
| 43Moderate | MEDIFAST INC | Michael A. Hoer director | $3,428 50 shares | +1% | |
| 43Moderate | MEDIFAST INC | Scott Schlackman director | $3,627 53 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.